c-LEcta GmbH
Biljana Mitrova has extensive experience in biopharma and food industry innovation, currently serving as Biopharma Innovation Manager at c-LEcta GmbH since August 2020, with previous roles including Business Development Manager and Business Development Associate. Responsibilities encompass product management, market intelligence, and customer support. Prior to this, Biljana worked at the University of Potsdam as an Academic Associate and Research Assistant, focusing on enzyme biosensor development and electrochemical studies. Biljana's academic background includes a PhD in Bioanalytics from the University of Potsdam, a Master's in Chemical Sciences from Ss. Cyril and Methodius University, and a Bachelor's in Chemical Engineering from the same institution. Additional experience includes teaching and research internships across various settings, highlighting expertise in analytical chemistry and project management.
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.